Fe²⁺-activated reactive oxygen species amplification via metal-organic frameworks loaded with paclitaxel for enhanced radiosensitivity in breast cancer radiotherapy.
- DOI
- 10.1016/j.xphs.2026.104285
- Published
- 2026 Aug
- Container
- Journal of pharmaceutical sciences
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.xphs.2026.104285,
title = {Fe²⁺-activated reactive oxygen species amplification via metal-organic frameworks loaded with paclitaxel for enhanced radiosensitivity in breast cancer radiotherapy.},
author = {Daliri Sosefi Z and Ghorbani M and Khoshkar Foshtomi M and Naseri AR and Jalili J J and Farajollahi AR},
year = {2026},
journal = {Journal of pharmaceutical sciences},
doi = {10.1016/j.xphs.2026.104285},
url = {https://doi.org/10.1016/j.xphs.2026.104285}
}RIS
TY - JOUR TI - Fe²⁺-activated reactive oxygen species amplification via metal-organic frameworks loaded with paclitaxel for enhanced radiosensitivity in breast cancer radiotherapy. AU - Daliri Sosefi Z AU - Ghorbani M AU - Khoshkar Foshtomi M AU - Naseri AR AU - Jalili J J AU - Farajollahi AR PY - 2026 JO - Journal of pharmaceutical sciences DO - 10.1016/j.xphs.2026.104285 UR - https://doi.org/10.1016/j.xphs.2026.104285 ER -
APA
Z, D. S., M, G., M, K. F., AR, N., J, J. J., & AR, F. (2026). Fe²⁺-activated reactive oxygen species amplification via metal-organic frameworks loaded with paclitaxel for enhanced radiosensitivity in breast cancer radiotherapy.. Journal of pharmaceutical sciences. https://doi.org/10.1016/j.xphs.2026.104285
Source records
- pubmed · retrieved 2026-09-25T13:24:48.783Z
- europe-pmc · retrieved 2026-09-25T13:24:48.805Z